Literature DB >> 16035729

Heart-fatty acid-binding protein as a marker for early detection of acute myocardial infarction and stroke.

Pierre Lescuyer1, Laure Allard, Denis F Hochstrasser, Jean-Charles Sanchez.   

Abstract

Heart-fatty acid-binding protein (H-FABP) is a small cytosolic protein involved in intracellular fatty acid transport. This protein, highly concentrated in the heart, is quickly released into plasma after myocardial injury. Results from numerous studies suggest that H-FABP is an excellent marker for the early detection of myocardial damage. H-FABP is also expressed in the brain, although in lower concentrations than in the heart. Recent preliminary studies also investigated the usefulness of H-FABP for the diagnosis of acute and chronic neurological disorders. These potential applications of H-FABP in clinical practice are reviewed in this article, with a strong focus on the early diagnosis of acute myocardial infarction and stroke.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16035729     DOI: 10.2165/00066982-200509010-00001

Source DB:  PubMed          Journal:  Mol Diagn        ISSN: 1084-8592


  67 in total

Review 1.  The human plasma proteome: history, character, and diagnostic prospects.

Authors:  N Leigh Anderson; Norman G Anderson
Journal:  Mol Cell Proteomics       Date:  2002-11       Impact factor: 5.911

2.  Influence of age and sex and day-to-day and within-day biological variation on plasma concentrations of fatty acid-binding protein and myoglobin in healthy subjects.

Authors:  M M Pelsers; J P Chapelle; M Knapen; C Vermeer; A M Muijtjens; W T Hermens; J F Glatz
Journal:  Clin Chem       Date:  1999-03       Impact factor: 8.327

3.  Human heart-type cytoplasmic fatty acid-binding protein as an indicator of acute myocardial infarction.

Authors:  K Yoshimoto; T Tanaka; K Somiya; R Tsuji; F Okamoto; K Kawamura; Y Ohkaru; K Asayama; H Ishii
Journal:  Heart Vessels       Date:  1995       Impact factor: 2.037

4.  Determination in human cerebrospinal fluid of glial fibrillary acidic protein, S-100 and myelin basic protein as indices of non-specific or specific central nervous tissue pathology.

Authors:  M Noppe; R Crols; D Andries; A Lowenthal
Journal:  Clin Chim Acta       Date:  1986-03-16       Impact factor: 3.786

5.  Release of brain-type and heart-type fatty acid-binding proteins in serum after acute ischaemic stroke.

Authors:  Michael T Wunderlich; Thorsten Hanhoff; Michael Goertler; Friedrich Spener; Jane F C Glatz; Claus-W Wallesch; Maurice M A L Pelsers
Journal:  J Neurol       Date:  2005-04-18       Impact factor: 4.849

6.  Traumatic brain damage: serum S-100 protein measurements related to neuroradiological findings.

Authors:  B Romner; T Ingebrigtsen; P Kongstad; S E Børgesen
Journal:  J Neurotrauma       Date:  2000-08       Impact factor: 5.269

7.  Serum concentrations of myoglobin vs human heart-type cytoplasmic fatty acid-binding protein in early detection of acute myocardial infarction.

Authors:  J Ishii; J H Wang; H Naruse; S Taga; M Kinoshita; H Kurokawa; M Iwase; T Kondo; M Nomura; Y Nagamura; Y Watanabe; H Hishida; T Tanaka; K Kawamura
Journal:  Clin Chem       Date:  1997-08       Impact factor: 8.327

8.  Assessment of coronary reperfusion in patients with myocardial infarction using fatty acid binding protein concentrations in plasma.

Authors:  M J de Groot; A M Muijtjens; M L Simoons; W T Hermens; J F Glatz
Journal:  Heart       Date:  2001-03       Impact factor: 5.994

9.  Isolation and characterization of two fatty acid binding proteins from mouse brain.

Authors:  S C Myers-Payne; T Hubbell; L Pu; F Schnütgen; T Börchers; W G Wood; F Spener; F Schroeder
Journal:  J Neurochem       Date:  1996-04       Impact factor: 5.372

10.  Thrombolytic therapy does not change the release ratios of enzymatic and non-enzymatic myocardial marker proteins.

Authors:  K W Wodzig; J A Kragten; W Modrzejewski; J Górski; M P van Dieijen-Visser; J F Glatz; W T Hermens
Journal:  Clin Chim Acta       Date:  1998-04-27       Impact factor: 3.786

View more
  5 in total

1.  Heart-type fatty acid binding protein and vascular endothelial growth factor: cerebrospinal fluid biomarker candidates for Alzheimer's disease.

Authors:  Liang-Hao Guo; Panagiotis Alexopoulos; Robert Perneczky
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-04-17       Impact factor: 5.270

2.  Early measurement of interleukin-10 predicts the absence of CT scan lesions in mild traumatic brain injury.

Authors:  Linnéa Lagerstedt; Juan José Egea-Guerrero; Ana Rodríguez-Rodríguez; Alejandro Bustamante; Joan Montaner; Amir El Rahal; Elisabeth Andereggen; Lara Rinaldi; Asita Sarrafzadeh; Karl Schaller; Jean-Charles Sanchez
Journal:  PLoS One       Date:  2018-02-21       Impact factor: 3.240

3.  H-FABP: A new biomarker to differentiate between CT-positive and CT-negative patients with mild traumatic brain injury.

Authors:  Linnéa Lagerstedt; Juan José Egea-Guerrero; Alejandro Bustamante; Joan Montaner; Ana Rodríguez-Rodríguez; Amir El Rahal; Natacha Turck; Manuel Quintana; Roser García-Armengol; Carmen Melinda Prica; Elisabeth Andereggen; Lara Rinaldi; Asita Sarrafzadeh; Karl Schaller; Jean-Charles Sanchez
Journal:  PLoS One       Date:  2017-04-18       Impact factor: 3.240

4.  Combining H-FABP and GFAP increases the capacity to differentiate between CT-positive and CT-negative patients with mild traumatic brain injury.

Authors:  Linnéa Lagerstedt; Juan José Egea-Guerrero; Alejandro Bustamante; Ana Rodríguez-Rodríguez; Amir El Rahal; Manuel Quintana-Diaz; Roser García-Armengol; Carmen Melinda Prica; Elisabeth Andereggen; Lara Rinaldi; Asita Sarrafzadeh; Karl Schaller; Joan Montaner; Jean-Charles Sanchez
Journal:  PLoS One       Date:  2018-07-09       Impact factor: 3.240

5.  A combined CXCL10, CXCL8 and H-FABP panel for the staging of human African trypanosomiasis patients.

Authors:  Alexandre Hainard; Natalia Tiberti; Xavier Robin; Veerle Lejon; Dieudonné Mumba Ngoyi; Enock Matovu; John Charles Enyaru; Catherine Fouda; Joseph Mathu Ndung'u; Frédérique Lisacek; Markus Müller; Natacha Turck; Jean-Charles Sanchez
Journal:  PLoS Negl Trop Dis       Date:  2009-06-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.